| Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies A Abou Zahr, ME Salama, N Carreau, D Tremblay, S Verstovsek, R Mesa, ... Haematologica 101 (6), 660, 2016 | 194 | 2016 |
| Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 L Naymagon, N Zubizarreta, J Feld, M van Gerwen, M Alsen, S Thibaud, ... Thrombosis research 196, 99-105, 2020 | 166 | 2020 |
| Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study D Tremblay, M Van Gerwen, M Alsen, S Thibaud, A Kessler, S Venugopal, ... Blood, The Journal of the American Society of Hematology 136 (1), 144-147, 2020 | 155 | 2020 |
| Risk factors and outcomes of COVID‐19 in New York City; a retrospective cohort study M van Gerwen, M Alsen, C Little, J Barlow, E Genden, L Naymagon, ... Journal of medical virology 93 (2), 907-915, 2021 | 137 | 2021 |
| Outcomes of patients with hypothyroidism and COVID-19: a retrospective cohort study M Van Gerwen, M Alsen, C Little, J Barlow, L Naymagon, D Tremblay, ... Frontiers in endocrinology 11, 565, 2020 | 113 | 2020 |
| Ferritin levels in patients with COVID‐19: a poor predictor of mortality and hemophagocytic lymphohistiocytosis J Feld, D Tremblay, S Thibaud, A Kessler, L Naymagon International journal of laboratory hematology 42 (6), 773-779, 2020 | 104 | 2020 |
| The impact of socioeconomic status on the clinical outcomes of COVID-19; a retrospective cohort study C Little, M Alsen, J Barlow, L Naymagon, D Tremblay, E Genden, ... Journal of community health, 1-9, 2021 | 103 | 2021 |
| Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID‐19 S Thibaud, D Tremblay, S Bhalla, B Zimmerman, K Sigel, J Gabrilove British journal of haematology 190 (2), e73, 2020 | 92 | 2020 |
| COVID‐19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient F Beerkens, M John, B Puliafito, V Corbett, C Edwards, D Tremblay American journal of hematology 95 (7), E154-E156, 2020 | 92 | 2020 |
| Does androgen deprivation therapy protect against severe complications from COVID-19? VG Patel, X Zhong, B Liaw, D Tremblay, CK Tsao, MD Galsky, WK Oh Annals of Oncology 31 (10), 1419-1420, 2020 | 86 | 2020 |
| The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis L Naymagon, D Tremblay, N Zubizarreta, E Moshier, K Troy, T Schiano, ... Blood advances 4 (4), 655-666, 2020 | 85 | 2020 |
| Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis L Ronner, N Podoltsev, J Gotlib, ML Heaney, AT Kuykendall, C O’Connell, ... Blood, The Journal of the American Society of Hematology 135 (19), 1696-1703, 2020 | 68 | 2020 |
| Cancer care disparities during the COVID-19 pandemic: COVID-19 and cancer outcomes study AL Schmidt, Z Bakouny, S Bhalla, JA Steinharter, DA Tremblay, MM Awad, ... Cancer cell 38 (6), 769-770, 2020 | 67 | 2020 |
| The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes L Naymagon, D Tremblay, T Schiano, J Mascarenhas Journal of Thrombosis and Thrombolysis 49, 325-331, 2020 | 60 | 2020 |
| Convalescent plasma for the treatment of severe COVID‐19 infection in cancer patients D Tremblay, C Seah, T Schneider, S Bhalla, J Feld, L Naymagon, B Wang, ... Cancer medicine 9 (22), 8571-8578, 2020 | 46 | 2020 |
| Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients T Barbui, V De Stefano, A Carobbio, A Iurlo, A Alvarez-Larran, B Cuevas, ... Leukemia 35 (10), 2989-2993, 2021 | 44 | 2021 |
| Safety and efficacy: clinical experience of venetoclax in combination with hypomethylating agents in both newly diagnosed and relapsed/refractory advanced myeloid malignancies J Feld, D Tremblay, M Dougherty, T Czaplinska, G Sanchez, C Brady, ... Hemasphere 5 (4), e549, 2021 | 38 | 2021 |
| Overview of myeloproliferative neoplasms: history, pathogenesis, diagnostic criteria, and complications D Tremblay, A Yacoub, R Hoffman Hematology/Oncology Clinics 35 (2), 159-176, 2021 | 35 | 2021 |
| Safety, efficacy, and long-term outcomes of anticoagulation in cirrhotic portal vein thrombosis L Naymagon, D Tremblay, N Zubizarreta, E Moshier, J Mascarenhas, ... Digestive Diseases and Sciences 66, 3619-3629, 2021 | 34 | 2021 |
| Next generation therapeutics for the treatment of myelofibrosis D Tremblay, J Mascarenhas Cells 10 (5), 1034, 2021 | 34 | 2021 |
